Uloric and Hyperhidrosis - a phase IV clinical study of FDA data

Summary:

Hyperhidrosis is reported as a side effect among people who take Uloric (febuxostat), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Lyrica, and have High blood pressure.

The phase IV clinical study analyzes which people have Hyperhidrosis when taking Uloric. It is created by eHealthMe based on reports of 7,878 people who have side effects when taking Uloric from the FDA, and is updated regularly.

What is Uloric?

Uloric has active ingredients of febuxostat. It is often used in gout. eHealthMe is studying from 8,067 Uloric users. Check the latest studies of Uloric.

What is Hyperhidrosis?

Hyperhidrosis (abnormally increased sweating) is found to be associated with 2,546 drugs and 3,546 conditions by eHealthMe. Check the latest studies of Hyperhidrosis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 26, 2026

7,878 people reported to have side effects when taking Uloric.
Among them, 43 people (0.55%) have Hyperhidrosis.

Among these 43 people:

How long have people been on Uloric when they have Hyperhidrosis? *

What is the gender of people who have Hyperhidrosis when taking Uloric? *

female: 27.5 %
male: 72.5 %

What is the age of people who have Hyperhidrosis when taking Uloric? *

What are other drugs people take besides Uloric? *

What are other side effects people have besides Hyperhidrosis? *

Drug Ineffective: 12 people, 27.91%
Nausea (feeling of having an urge to vomit): 12 people, 27.91%
Fatigue (feeling of tiredness): 12 people, 27.91%
Diarrhea: 11 people, 25.58%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 11 people, 25.58%
Weakness: 10 people, 23.26%
Dyspnea (difficult or laboured breathing): 9 people, 20.93%
Feeling Abnormal: 8 people, 18.60%
Joint Pain: 8 people, 18.60%
Tremor (trembling or shaking movements in one or more parts of your body): 8 people, 18.60%

What are the existing conditions these people have? *

High Blood Pressure: 12 people, 27.91%
Pain: 8 people, 18.60%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 7 people, 16.28%
Hypersensitivity: 6 people, 13.95%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 13.95%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 13.95%
Neuropathy Peripheral (surface nerve damage): 6 people, 13.95%
Muscle Spasms (muscle contraction): 5 people, 11.63%
Back Pain: 4 people, 9.30%
Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 6.98%

* Approximation only. Some reports may have incomplete information.

Do you take Uloric and have Hyperhidrosis?

- Check whether Hyperhidrosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Uloric:

Uloric (8,067 reports)

Hyperhidrosis treatments and more:

Hyperhidrosis (147,206 reports)

Browse all side effects of Uloric:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperhidrosis:

Hyperhidrosis (2,546 drugs)

Browse all the conditions that are associated with Hyperhidrosis:

Hyperhidrosis (3,546 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on febuxostat (the active ingredients of Uloric) and Uloric (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.